Form 8-K - Current report:
SEC Accession No. 0000875320-19-000046
Filing Date
2019-09-17
Accepted
2019-09-17 17:08:24
Documents
14
Period of Report
2019-09-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement

Document Format Files

Seq Description Document Type Size
1 8-K a8-ksep2019creditfacil.htm   iXBRL 8-K 40151
  Complete submission text file 0000875320-19-000046.txt   185170

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20190917.xsd EX-101.SCH 4654
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20190917_cal.xml EX-101.CAL 693
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20190917_def.xml EX-101.DEF 1543
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20190917_lab.xml EX-101.LAB 26142
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20190917_pre.xml EX-101.PRE 13649
11 EXTRACTED XBRL INSTANCE DOCUMENT a8-ksep2019creditfacil_htm.xml XML 4357
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19319 | Film No.: 191097677
SIC: 2834 Pharmaceutical Preparations